| Literature DB >> 28478369 |
Koon Jiew Chua1, Wee Chiew Kwok1, Nikhil Aggarwal1, Tao Sun1, Matthew Wook Chang2.
Abstract
Various studies have shown the beneficial effects of probiotics in humans. The use of synthetic biology to engineer programmable probiotics that specifically targets cancer, infectious agents, or other metabolic diseases has gained much interest since the last decade. Developments made in synthetic probiotics as therapeutics within the last three years will be discussed in this review.Entities:
Mesh:
Year: 2017 PMID: 28478369 DOI: 10.1016/j.cbpa.2017.04.011
Source DB: PubMed Journal: Curr Opin Chem Biol ISSN: 1367-5931 Impact factor: 8.822